0001585608-17-000002.txt : 20170830 0001585608-17-000002.hdr.sgml : 20170830 20170830172423 ACCESSION NUMBER: 0001585608-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170830 DATE AS OF CHANGE: 20170830 EFFECTIVENESS DATE: 20170830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293814 FILM NUMBER: 171061486 BUSINESS ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-896-5081 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 D 1 primary_doc.xml X0708 D LIVE 0001585608 Jaguar Health, Inc. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA CALIFORNIA 94105 415-896-5081 DELAWARE Jaguar Animal Health, Inc. Corporation true 2013 Lisa Conte 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Executive Officer Director Zhi Yang 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director Joe Qui 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director James Bochnowski 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director John Micek, III 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director Folkert Kamphuis 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director Ari Azhir 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Director Karen Wright 201 Mission Street, Suite 2375 San Francisco CA CALIFORNIA 94105 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2017-07-31 false true true true true Shares of voting common stock, shares of non-voting common stock, and warrants exercisable for shares of voting common stock true Shares issued in connection with the Issuer?s acquisition of Napo Pharmaceuticals, Inc. ("Napo") pursuant to the Agreement and Plan of Merger, dated March 31, 2017, by and among the Issuer, Napo, Napo Acquisition Corporation, and Napo's representative. 0 44796553 44796553 0 The total offering amount is based on 48,428,706 total aggregate amount of shares of voting common stock and non-voting common stock issued in connection with the merger and related transactions at a deemed value of $0.925 per share. See Item 10. false 10 0 0 0 false Jaguar Health, Inc. /s/ Karen S. Wright Karen S. Wright Chief Financial Officer 2017-08-28